U.K. manufacturer Abzena pumps $60M into new biologics facility in San Diego kblankenship Fri, 10/09/2020 – 08:46
There is great potential in gene therapy for treating certain types of cancer and genetic defects, immunological diseases, […]
Brain science is still in a discovery phase because of our limited knowledge of basic nervous system structure […]
Cerebrovascular diseases and dementia are two leading contributors to impairment of brain health and neurological disability in older […]
Monogenic diseases result from modifications to a single gene. Over 10 000 monogenic diseases have been identified, around […]
Fadraciclib has passed safety trials and shown early efficacy
Partnership will aim to prevent cardiovascular events across the North West Coast of England
Testing Alliance created to offer 20,500 extra coronavirus tests a day
Advance purchase agreement follows initial exploratory talks
